The prolonged use of new drugs such as proteasome inhibitors, immunomodulators, and monoclonal antibodies in the treatment of multiple myeloma is associated with adverse side effects that represent a daily challenge for physicians. We propose a series of recommendations based on clinical cases. Key Words Multiple myeloma, side effect, proteasome inhibitor, immunomodulator, monoclonal antibody, case report
Side effects of multiple myeloma treatments
Back
Published in the journal : January 2020
Category : Hematology/Oncology